SUN Ping-nan，ZHOU Xiao-ling，YANG Shao-zhe，CHENG Lin，YAO Wei-cheng. Human embryonic stem cell-derived hepatocytes： a potential model for hepatitis B virus[J]. Carcinogenesis, Teratogenesis & Mutagenesis, doi: 10.3969/j.issn.1004-616x.2014.05.004.
[1] Sun P，Zhou X，Farnworth SL，et al. Modeling human liver biology using stem cell-derived hepatocytes[J]. Int J Mol Sci，2013，14(11)：22011-22021.[2] Schwartz RE，Trehan K，Andrus L，et al. Modeling hepatitis C virus infection using human induced pluripotent stem cells[J]. PNAS USA，2012，109(7)：2544-2548.[3] Roelandt P，Obeid S，Paeshuyse J，et al. Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus[J]. J Hepatol，2012，57(2)：246-251.[4] Wu X，Robotham JM，Lee E，et al. Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation[J]. PLoS Pathog，2012，8：e1002617.[5] Zhou X，Sun P，Lucendo-Villarin B，et al. Modulating innate immunity improves hepatitis C virus infection and Replication in stem cell-derived hepatocytes[J]. Stem Cell Reports， 2014， 3(1)：204-214.[6] Sun P，Zheng J，She G，et al. Expression pattern of asialoglycoprotein receptor in human testis[J]. Cell Tissue Res，2013，352(3)：761-768.[7] Yan H，Zhong G，Xu G，et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus[J]. Elife，2012，1：e00049.[8] Zhou XL，Sullivan GJ，Sun P，et al. Humanized murine model for HBV and HCV using human induced pluripotent stem cells[J]. Arch Pharm Res，2012，35(2)：261-269.
